Punch & Associates Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,222
Closed -$250K 238
2022
Q4
$250K Buy
3,222
+22
+0.7% +$1.78K 0.02% 194
2022
Q3
$258K Hold
3,200
0.02% 195
2022
Q2
$287K Hold
3,200
0.02% 199
2022
Q1
$355K Buy
3,200
+100
+3% +$10.6K 0.02% 198
2021
Q4
$321K Hold
3,100
0.02% 203
2021
Q3
$389K Buy
3,100
+400
+15% +$51.8K 0.02% 198
2021
Q2
$335K Sell
2,700
-69
-2% -$8.66K 0.02% 204
2021
Q1
$327K Hold
2,769
0.02% 210
2020
Q4
$324K Sell
2,769
-39
-1% -$4.29K 0.02% 204
2020
Q3
$292K Hold
2,808
0.03% 205
2020
Q2
$258K Hold
2,808
0.02% 208
2020
Q1
$253K Buy
+2,808
New +$299K 0.03% 198
2016
Q1
Sell
-1,440
Closed -$111K 206
2015
Q4
$111K Buy
+1,440
New +$108K 0.01% 189
2014
Q3
Sell
-17,964
Closed -$1.15M 178
2014
Q2
$1.15M Sell
17,964
-200
-1% -$12.2K 0.15% 156
2014
Q1
$1.12M Hold
18,164
0.15% 155
2013
Q4
$1.04M Hold
18,164
0.14% 158
2013
Q3
$967K Hold
18,164
0.15% 154
2013
Q2
$935K Buy
+18,164
New +$898K 0.16% 156

Other funds holding MDT

Punch & Associates Investment Management's MDT Position: Q1 2023 in Review

Punch & Associates Investment Management sold out of Medtronic (MDT) in Q1 2023, closing a stake of 3,222 shares — an estimated $250K sold.

Punch & Associates Investment Management first reported a position in MDT in Q2 2013 and held it in 18 quarters. The position peaked at $1.15M in Q2 2014. 1,991 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

  • Punch & Associates Investment Management reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
  • Punch & Associates Investment Management sold 3,222 Medtronic shares in Q1 2023, an estimated $250K.
  • Punch & Associates Investment Management first reported a position in Medtronic in Q2 2013 and held it in 18 quarters.
  • Punch & Associates Investment Management's Medtronic position peaked at $1.15M in Q2 2014.
  • 1,991 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Punch & Associates Investment Management's 13F filing for Q1 2023, filed 15 May 2023.